JOSEP
REDON MAS
CATEDRÁTICO/A DE UNIVERSIDAD
Beijing Anzhen Hospital
Pekín, ChinaPublicaciones en colaboración con investigadores/as de Beijing Anzhen Hospital (3)
2016
-
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke
Journal of Hypertension, Vol. 34, Núm. 3, pp. 393-396
2014
-
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial
Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897
-
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence
Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750